IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $170,570 | -31.6% | 37,488 | +5.8% | 0.00% | -100.0% |
| Q2 2023 | $249,413 | -4.2% | 35,428 | -16.8% | 0.00% | 0.0% |
| Q1 2023 | $260,219 | +6.4% | 42,589 | +6.4% | 0.00% | 0.0% |
| Q4 2022 | $244,492 | +50.9% | 40,015 | +136.4% | 0.00% | 0.0% |
| Q3 2022 | $162,000 | -6.9% | 16,925 | +7.3% | 0.00% | 0.0% |
| Q2 2022 | $174,000 | -34.8% | 15,776 | -1.4% | 0.00% | 0.0% |
| Q1 2022 | $267,000 | -7.3% | 16,007 | +6.0% | 0.00% | 0.0% |
| Q4 2021 | $288,000 | -38.1% | 15,098 | -19.9% | 0.00% | -50.0% |
| Q3 2021 | $465,000 | -5.3% | 18,851 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $491,000 | +51.5% | 18,851 | +84.1% | 0.00% | +50.0% |
| Q1 2021 | $324,000 | +5.5% | 10,241 | +55.0% | 0.00% | 0.0% |
| Q4 2020 | $307,000 | +72.5% | 6,608 | +21.9% | 0.00% | 0.0% |
| Q3 2020 | $178,000 | +24.5% | 5,421 | +3.8% | 0.00% | 0.0% |
| Q2 2020 | $143,000 | -37.8% | 5,222 | -32.1% | 0.00% | -50.0% |
| Q1 2020 | $230,000 | +42.9% | 7,687 | +21.9% | 0.00% | +100.0% |
| Q4 2019 | $161,000 | -0.6% | 6,307 | -29.0% | 0.00% | -33.3% |
| Q3 2019 | $162,000 | -9.5% | 8,881 | +21.4% | 0.00% | 0.0% |
| Q2 2019 | $179,000 | +17.0% | 7,317 | -54.6% | 0.00% | 0.0% |
| Q1 2019 | $153,000 | +11.7% | 16,122 | +4.9% | 0.00% | 0.0% |
| Q4 2018 | $137,000 | +31.7% | 15,374 | +66.9% | 0.00% | +50.0% |
| Q3 2018 | $104,000 | – | 9,212 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |